Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIMETIC: 18F-PSMA PET/CT in Medullary Thyroid Cancer
NCT05534594Completed
- Sponsor
- University Medical Center Groningen
- Start
- Aug 2022
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by University Medical Center Groningen. Primary endpoint: Sensitivity of 18F-PSMA PET/CT up to 2 years. Started Aug 2022; status: completed.
Beyond the preview
Go deeper on NCT05534594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05534594.